Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3 ...

They then compared these effects to a control group of more than one million individuals who received different types of anti-diabetic drugs. Data on all participants was obtained from the U.S ...

The authors point out that other classes of drugs, including those treating erectile dysfunction and an anti-arrythmic drug ... first place because they have diabetes or obesity, as well as ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.